Ligand Reports Second Quarter 2021 Financial Results
Go back to Ligand Reports Second Quarter 2021 Financial Results| LIGAND PHARMA (NASDAQ: LGND) | Delayed: 286.53 +7.09 (2.54%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $279.44 | 52 Week High | $139.79 | |||
| Open | $283.35 | 52 Week Low | $82.07 | |||
| Day High | $288.46 | P/E | 666.35 | |||
| Day Low | $278.65 | EPS | $0.43 | |||
| Volume | 359,561 | |||||

